// App-Quantinova.ai

537 : Health outcomes of gBRCA testing strategies for metastatic pancreatic cancer patients.

Researchers

Presenter

  • Lin Fan

Principal Investigators

  • Neeharika Agnihotri

  • Apoorva Ambavane

  • Weiyan Li

  • Seongjung Joo

  • Hyun Kyoo Yoo

  • Dominic Muston

Medical Centers

  • Merck & Co., Inc., Kenilworth, NJ

  • Evidera, Inc., London, United Kingdom

  • Evidera, London, MD, United Kingdom

  • AstraZeneca, Gaithersburg, MD

  • Merck & Co., Inc., Kenilworth, NJ

  • Merck, Kenilworth, NJ

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Metastatic pancreatic adenocarcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Olaparib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved